Anti-CD40 antibodies and uses thereof
US11306149B2 · kind B2 · utility
1Cited by
48References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 27, 2018 |
| Grant date | Apr 19, 2022 |
| Priority date | — |
| Expiry date | Dec 27, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Provided herein are agonistic antibodies, or antigen binding portions thereof, that bind to human CD40 and comprise improved heavy and light chain variable regions that impart improved yield and reduced aggregation. The invention also provides methods of treatment of cancer or chronic infection by administering the antibodies of the invention to a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.